The six questions of pathogen reduction technology: An overview of current opinions

Transfusion and Apheresis Science

Volumn 39, Issue 1, 2008, Pages 51-57

  Solheim, Bjarte G ^a   Seghatchian, Jerard ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b Blood Components/Apheresis Technology and Haemostasis/Thrombosis Consultancy   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOSAFETY; BLOOD TRANSFUSION; DISEASE TRANSMISSION; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; GAMMA IRRADIATION; HUMAN; INFECTION PREVENTION; MEDICAL TECHNOLOGY; PLASMA TRANSFUSION; QUALITY CONTROL; SERODIAGNOSIS; THROMBOCYTE TRANSFUSION; ULTRAVIOLET IRRADIATION;

BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD DONORS; DISINFECTION; DONOR SELECTION; HUMANS; SAFETY;

EID: 47349125880     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2008.05.007     Document Type: Article

References (11)

1. Seghatchian J., and de Sousa G. Pathogen-reduction systems for blood components: the current and future trends. Transfus Apheresis Sci 35 (2006) 189-196
2. Solheim B.G., and Seghatchian J. Update on pathogen reduction technology for therapeutic plasma: an overview. Transfus Apheresis Sci 35 (2006) 83-90
3. Pelletier J.P.R., Transue S., and Snyder E.L. Pathogen inactivation techniques. Best Practice Res Clin Haemat 19 (2006) 205-242
4. Solheim B.G., Cid J., and Osselaer J.-C. Pathogen reduction technologies. In: Lonzano M., Contreras M., and Blajchman M. (Eds). Global perspectives in transfusion medicine (2006), AABB Press, Bethesda, MD, USA 103-148
5. Solheim BG. Pathogen reduction of blood components. Transfus Apheresis Sci current issue.
6. Svae T-E, Neisser-Svae A, Bailey A, Reichl H, Biesert L, Schmidt T, et al. Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment. Transfus Apheresis Sci current issue.
7. Hellstern P. Fresh-frozen plasma, pathogen-reduced single donor plasma or bio-pharmaceutical plasma? Transfus Apheresis Sci current issue.
8. Burnouf T., Goubran H.A., Radosevich M., Sayed M.A., Gorgy G., and El-Ekiaby M. A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable-bag system. Transfusion 46 (2006) 2100-2108
9. Burnouf T., Goubran H.A., Radosevich M., Sayed M.A., Gorgy G., and El-Ekiaby M. A minipool process for solvent-detergent treatment of cryoprecipitate at blood centers using a disposable bag system. Vox Sang 91 (2006) 56-62
10. Depasse F., Sensebe L., Seghatchian J., Andreu G., and Samama M.M. The influence of methylene blue light treatment and methylene blue removal filter on fibrinogen activity states and fibrin polymerization indices. Transfus Apheresis Sci 33 (2005) 63-69
11. Seghatchian J. Guest Editorial: the state of the art on platelet/red cell concentrates and MBLT-treated FFP the need for an absolute standard and standardized approach. Transfus Apheresis Sci 33 (2005) 53